Cargando…

Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access

Cellular therapies and other regenerative medicines are emerging as potentially transformative additions to modern medicine, but likely at a staggering financial cost. Public health care systems’ budgets are already strained by growing and aging populations, and many private insurer's budgets a...

Descripción completa

Detalles Bibliográficos
Autores principales: Driscoll, Dawn, Farnia, Stephanie, Kefalas, Panos, Maziarz, Richard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689744/
https://www.ncbi.nlm.nih.gov/pubmed/28749065
http://dx.doi.org/10.1002/sctm.16-0487